Showing 21 - 23 results of 23 for search '"Cancer Treatment and Research Communications"', query time: 0.04s Refine Results
  1. 21
    Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations

    Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations by Jason C.S. Ho, K.M. Cheung

    Published 2024-01-01
    “…Cancer Treatment and Research Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 22
    Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report

    Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report by Oliver Illini, Anna Sophie Lang-Stöberl, Hannah Fabikan, Christoph Weinlinger, Arschang Valipour, Maximilian J. Hochmair

    Published 2024-01-01
    “…Cancer Treatment and Research Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 23
    The impact of PD-L1 expression status on the prognosis of ALK-positive lung cancer patients

    The impact of PD-L1 expression status on the prognosis of ALK-positive lung cancer patients by Li Wang, Yingjun Kong, Yao Zhang, Chuanyong Mu

    Published 2024-01-01
    “…Cancer Treatment and Research Communications…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: